Position in ARGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$737,577
-$158,439 QoQ
Shares Held
795
-35.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#277
of 504 holders
Holding Since
Dec 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FLOW TRADERS U.S. LLC holds $1,634,905 across 8 Biotechnology names. ARGX ranks #1 (45.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
This page
|
795 | $737,577 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,371 | $681,016 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
715 | $215,236 | |
| 4 | SGMOQ |
Sangamo Therapeutics, Inc
|
21,532 | $1,076 | |
| 5 | OSRH |
OSR Health, Inc.
|
24,173 | $0 | |
| 6 | ASBP |
Aspire Biopharma Holdings, Inc.
|
15,450 | $0 | |
| 7 | TVGN |
Tevogen Inc.
|
17,649 | $0 | |
| 8 | LIMN |
Liminatus Pharma, Inc.
|
13,110 | $0 |
All Filings in ARGX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $737,577 | 795 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $896,016 | 1,227 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $520,717 | 706 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $313,688 | 530 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $244,770 | 398 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||